[HTML] mdpi.com

[HTML][HTML] Gamma-Delta T-cell phenotype and function in DAA-Treated HIV-HCV Co-Infected and HCV-mono-infected subjects

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - Viruses, 2022 - mdpi.com
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …
被引用次数：1 相关文章

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - VIRUSES, 2022 - air.unimi.it
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …
[PDF] semanticscholar.org

[PDF][PDF] Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects. Viruses 2022, 14, 1594

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - 2022 - pdfs.semanticscholar.org
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

V Bono, C Tincati, L Van Den Bogaart… - …, 2022 - pubmed.ncbi.nlm.nih.gov
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …
[PDF] researchgate.net

[PDF][PDF] Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects. Viruses 2022, 14, 1594

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - 2022 - researchgate.net
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …
[HTML] nih.gov

[HTML][HTML] Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - Viruses, 2022 - ncbi.nlm.nih.gov
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - agris.fao.org
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …

Gamma-Delta T-cell phenotype and function in DAA-treated HIV-HCV co-infected and HCV-mono-infected subjects.

V Bono, C Tincati, L van den Bogaart, ES Cannizzo… - 2022 - cabidigitallibrary.org
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects.

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - Viruses, 2022 - europepmc.org
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

V Bono, C Tincati, L Van Den Bogaart, ES Cannizzo… - …, 2022 - search.proquest.com
HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune
imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co …